Evista Coupons & Discount Card - Compare Prices Near You
raloxifene
My prescription
Edit
60MG, Raloxifene (30 Tablets)
Select pharmacy
CVS
$21.30
COUPON PRICE
Walmart
$10.94
COUPON PRICE
Rite Aid
$11.44
COUPON PRICE
Albertsons
$19.52
COUPON PRICE
Walgreens
$29.31
COUPON PRICEEvista savings card
Show this card to your pharmacistCVS
$21.30
BIN
ID
PCN
GRP
019876
LH95E151B1
CHIPPO
LHX
Powered by
Related estrogen agonist/antagonists prescriptions
More prescriptions for breast cancer
Related estrogen agonist/antagonists prescriptions
More prescriptions for breast cancer
Evista dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 60MG | 30 Tablets | $10.94 | $0.36 |
Evista Warnings
Raloxifene is a medication with significant safety considerations. It is essential for patients and healthcare providers to be aware of the potential risks and necessary precautions associated with its use. Here is a detailed overview:
Risk of Blood Clots and Stroke: Raloxifene may increase the likelihood of developing blood clots, especially during the initial four months of treatment. These clots can result in severe complications, such as strokes. Patients with a history of blood clots, strokes, or mini-strokes (TIA) should exercise caution. Additional risks include having heart disease, high blood pressure, atrial fibrillation, or being a smoker. Long periods of immobility can also elevate clot risks.
Risk to Specific Populations: Women who have experienced blood clots in the legs, lungs, or eyes should not use raloxifene. Those who have suffered a heart attack or are at risk for one may face an increased risk of fatal stroke when using this medication. Pregnant individuals should avoid raloxifene entirely.
High Triglyceride Levels: Raloxifene can exacerbate high triglyceride levels, particularly in those who have experienced this as a side effect of other estrogen medications. Regular blood tests are recommended to monitor triglyceride levels during treatment.
Breast Cancer Monitoring: Although raloxifene aids in breast cancer prevention, it does not eliminate the risk. Regular breast examinations and mammograms are crucial. Report any changes in breast appearance or feel to your healthcare provider immediately.
Drug Interactions: Caution is advised when using raloxifene in conjunction with warfarin (Coumadin), as it can heighten the risk of bleeding. Inform your healthcare provider of your raloxifene use if you are also on warfarin, as adjustments to medication or additional blood tests may be necessary. Look out for extended nosebleeds or severe bruising.
Contraindications: Raloxifene should not be used by individuals currently experiencing or with a history of blood clots, or those who are pregnant.
In case of suspected overdose or severe reactions, seek immediate medical attention. Always discuss with your healthcare provider to thoroughly weigh the benefits and risks of raloxifene in your specific health context.
Evista Side Effects
When taking this medication, some individuals may experience common side effects, which are generally mild. These include joint pain, flu-like symptoms, hot flashes, bronchitis, runny nose, cough, headache, nausea, sinus infection, leg cramps, diarrhea, and swelling in the arms or legs. If any of these side effects persist or worsen, it is advisable to consult your healthcare provider for guidance.
In addition to common side effects, other side effects such as vertigo, sweating, fever, vomiting, nerve pain, and urinary tract problems have been reported by some users. It is important to monitor these symptoms, and if they become severe, seek advice from your healthcare provider.
There are also serious side effects associated with this medication that, although rare, require immediate medical attention. These include signs of a blood clot, such as sudden leg or arm pain, swelling, redness, warmth, chest pain, trouble breathing, and coughing up blood. Signs of a stroke, such as sudden weakness on one side of the body, confusion, trouble speaking, severe headache, and sudden changes in vision, also demand urgent medical care.
While a very serious allergic reaction to this medication is rare, it is crucial to get medical help right away if you experience symptoms such as a rash, itching or swelling, severe dizziness, or trouble breathing. Always remain vigilant and contact your healthcare provider if you notice any unusual effects not listed here.
Evista Interactions
Who should not take Evista?
Evista (raloxifene) should not be taken by individuals who are pregnant or may become pregnant, as it can harm the fetus. It is also contraindicated in individuals with a history of blood clots, such as deep vein thrombosis, pulmonary embolism, or retinal vein thrombosis. Additionally, those with a known allergy to raloxifene or any of its components should avoid taking Evista. It is important for individuals to consult with their healthcare provider to determine if Evista is appropriate for their specific medical condition.
Which is better, Evista or Fosamax?
The choice between Evista (raloxifene) and Fosamax (alendronate) depends on the specific medical condition being treated and the individual patient's health profile. Evista is typically used for the prevention and treatment of osteoporosis in postmenopausal women and also reduces the risk of invasive breast cancer. Fosamax is used to treat and prevent osteoporosis in postmenopausal women and men, and it can also treat osteoporosis caused by glucocorticoid use and Paget's disease of bone.The decision on which medication is better should be made by a healthcare provider, considering factors such as the patient's medical history, risk factors, potential side effects, and specific health needs. It is important for patients to discuss their options with their healthcare provider to determine the most appropriate treatment for their situation.
Does Evista improve bone density?
Yes, Evista (raloxifene) is known to improve bone density. It is commonly used to treat and prevent osteoporosis in postmenopausal women by mimicking the effects of estrogen on bone tissue, which helps to maintain or increase bone density.
Is Evista the same as Prolia?
Evista and Prolia are not the same. Evista (raloxifene) is a selective estrogen receptor modulator (SERM) used primarily to treat and prevent osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer. Prolia (denosumab) is a monoclonal antibody used to treat osteoporosis in postmenopausal women at high risk for fracture and to increase bone mass in men with osteoporosis. They work through different mechanisms and are used for similar but distinct purposes.
What medical conditions should not take raloxifene?
Raloxifene should generally be avoided in individuals with a history of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as it may increase the risk of these conditions. It is also contraindicated in those with active or past history of blood clots. Additionally, raloxifene is not recommended for use in premenopausal women, during pregnancy, or in individuals with severe liver impairment. It is important for patients to consult with their healthcare provider to determine if raloxifene is appropriate for their specific medical condition.